SIBN SI-BONE, Inc.
8-K Current Report
Filed: February 23, 2026
Health Care
Surgical & Medical Instruments & ApparatusSI-BONE, Inc. (SIBN) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items3 items
- Item 1.01: Entry into a Material Definitive Agreement
- Item 2.02: Results of Operations and Financial Condition
- Item 5.02: Departure/Election of Directors or Officers
AI Filing Analysis8-K
Item 1.01 · Entry into a Material Definitive Agreement
- • New 102-month HQ lease at 88 W. Plumeria Dr., San Jose — ~50,485 sq ft, commencing no later than Oct 1, 2026
- • Monthly base rent starts at $128,737 (~$1.54M/year), escalating ~3% annually over the lease term
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released Feb 23, 2026 — full results in Exhibit 99.1
- • SIBN reports on minimally invasive sacropelvic procedures; results cover period ended Dec 31, 2025
Item 5.02 · Departure/Election of Directors or Officers
- • CFO Anshul Maheshwari, age 46, adds COO title effective Feb 22, 2026 — dual role consolidation, no new hire
- • Move signals cost discipline or streamlining of executive structure rather than external COO search
Get deeper insights on SI-BONE, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.